Skip to content
NewsBlazeIN – Lifestyle
Author:
Lupin Pharmaceuticals, Inc.
Lupin Spins Out Two Oncology Programs to Kaveri Therapeutics to Advance its Oncology Strategy
July 21, 2026
Lupin Receives Tentative Approval from U.S. FDA for Enzalutamide Tablets
June 26, 2026
Lupin Launches Azilsartan Medoxomil Tablets in the United States
June 17, 2026